

Cover Story
Free
By Matthew Bin Han Ong
The power morcellator should no longer be used for hysterectomies or fibroid removal in the vast majority of women getting these procedures, FDA declared in a highly anticipated guidance document Nov. 24.
In Brief


Drugs & Targets
Trending Stories
- GRAIL to use new study results to seek FDA approval of Galleri MCD test
- Class action complaint alleging GRAIL insider fraud resubmitted after dismissal
- Duke brain cancer researcher Kyle Walsh named director of NIEHS
- Cancer centers adapt to life without site visits as NIH changes CCSG review
- Trump cuts IVF drug deal with Merck in exchange for tariff exemption
- Jonathan Licht named president, chief scientific officer at Van Andel Institute











